MIAMI and WESTBURY, N.Y., Oct. 28, 2024 /PRNewswire/ -- PL Developments (PLD), a leader in the development, manufacturing, packaging, and distribution of consumer healthcare products, today announced two significant milestones: FDA approval for its Omeprazole OTC ANDA and the successful refinancing of its corporate debt.
FDA Approval for Omeprazole OTC
The FDA has granted approval for PLD's Omeprazole Magnesium Tablet, a product comparable to Prilosec® OTC. The product will be manufactured at PL